GB:HEMO Stock Latest News
Company AnnouncementsHemogenyx Partners with Nitto to Explore In Vivo Off-the-Shelf CAR-T Delivery2w ago
Company AnnouncementsHemogenyx clarifies total voting rights and share capital1M ago
Company AnnouncementsHemogenyx Advances AML CAR-T Trial and Sets Up Early European Commercial Pathways1M ago
Company AnnouncementsHemogenyx Raises £291,665 Through Warrant Exercises Ahead of LSE Admission2M ago
Company AnnouncementsHemogenyx Expands FLT3 CAR-T Effort With Vilnius Hospital Collaboration3M ago
Company AnnouncementsHemogenyx Wins Full Shareholder Backing at AGM, Secures New Capital Flexibility4M agoCompany AnnouncementsHemogenyx reshapes incentives with new options and extended investor warrants5M ago
Company AnnouncementsHemogenyx advances lead CAR-T trial and secures funding to complete Phase 16M ago
Company AnnouncementsHemogenyx Raises £3m to Accelerate HG-CT-1 Trials and Early Commercialisation6M ago
Company AnnouncementsHemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise6M ago
Company AnnouncementsHemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion7M ago
Company AnnouncementsHemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure8M agoCompany AnnouncementsHemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital8M ago
Company AnnouncementsHemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML8M ago
Company AnnouncementsHemogenyx Raises £2.5m to Advance AML CAR-T Trials and Reduce Costs8M ago
Company AnnouncementsHemogenyx Confirms Updated Share Capital and Voting Rights9M ago
Company AnnouncementsHemogenyx Sets Early January Date for Admission of New Shares10M ago
Company AnnouncementsHemogenyx Pharmaceuticals Announces Equity Issuance and Operational Updates10M ago
Company AnnouncementsHemogenyx Pharmaceuticals Publishes Prospectus for New Share Admission11M agoCompany AnnouncementsHemogenyx Pharmaceuticals Advances CAR-T Therapy Trial with DSMB Approval1y ago

